the insurance payer type segment significantly influences the procalcitonin, IL-6, and IL-10 tests market, with Medicare, Medicaid, and private insurance companies playing pivotal roles. Medicare may cover these tests when deemed medically necessary and ordered by a healthcare provider. This ...